Expected outcome: Potentially improved digestive comfort
These medications are administered subcutaneously, meaning they are injected into the fatty tissue layer beneath the skin rather than into muscle
Best candidates for retatrutide Retatrutide makes more sense for researchers who: Need maximum possible weight loss and have not achieved adequate results with dual agonists Have significant liver fat accumulation as a primary concern Have plateaued on tirzepatide or stopped responding Are comfortable with investigational compounds and research-grade sourcing Have higher side effect tolerance Want the most comprehensive metabolic intervention currently available Are experienced with GLP-1 agonist protocols and understand escalation management Have access to medical monitoring during the protocol Retatrutide is not a beginner compound
However, they differ in a few key ways, including: Medication focus: Ro focuses on FDA-approved, brand-name GLP-1 medications for weight loss
Strong-smelling foods like fish, garlic, and onions cause problems for many users
This distributed approach may explain why clinical trials show such impressive results without proportionally worse side effects
